Migraine Minute News Update: Recent Episodes
Association of Migraine Disorders
The Migraine Minute provides weekly updates in migraine research and news hosted by Molly O'Brien of the Association of Migraine Disorders.
A real-world study suggests one migraine preventive may be more effective than some commonly prescribed oral treatments at three months. Molly O'Brien breaks down the study in this Migraine Minute News Update.
Read More: https://bit.ly/3TpJmhM
Creative Commons: https://creativecommons.org/licenses/by-nc-nd/4.0/
Script: New research published in Headache, the Journal of Head and Face Pain, shows that one CGRP MAB may be more effective than some traditional oral preventives.
Triumph is an international, observational study that compared the effectiveness of galcanezumab, sold in the US under brand name Emgality, with other preventive treatments.
Researchers found that more people saw a meaningful drop in monthly migraine headache days at the three-month mark after starting galcanezumab compared to a traditional oral preventive like topiramate or amitriptyline. This was true for both episodic and chronic migraine patients.
Study authors say this evidence may help in clinical practice as it shows the effectiveness of treatments across diverse populations and healthcare settings. Authors also note limitations, including that short-term results may be biased because galcanezumab starts with a double dose and becomes effective quickly, while it takes time to gradually reach an effective dose of topiramate and amitriptyline.
Ever wonder if there was a way to make OnabotulinumtoxinA injections less painful? New research suggests using this treatment before injections may help. Molly O'Brien explains in this Migraine Minute news update.
Read the study: https://bit.ly/4wRHAFh
Script: For many people with chronic migraine, onabotulinumtoxinA, also known as Botox, is an effective treatment, but it can come with injection pain and post-treatment headache.
New research shows there may be an option to help ease that pain. A study published in HEADACHE, found that adults who used a REN, or Remote Electrical Neuromodulation device, felt less pain during injections. The study also found that only 15 percent of those who used the REN device reported post-treatment headache, compared with 55 percent of those who used the fake device.
The REN is sold under brand name Nerivio. It's a wearable, drug-free device that delivers electrical pulses to the arm, triggering the body's natural pain relief process.
Researchers say these results show Remote Electrical Neuromodulation could be a safe and easy way to make injection treatment sessions more comfortable.
Celebrating the Fourth of July with migraine is not easy. This festive holiday can be packed with sensory overload and migraine triggers. In this Migraine Minute, Molly O'Brien shares tips to help you enjoy the celebration while protecting your health.
Check out our triggers webpage: https://bit.ly/4kFOZRf
Script: While the Fourth of July can be a fun holiday to celebrate in the States, it can be tough for folks with migraine. Why? Well, there are so many factors that can be stacked against you. Think about it, heat, big crowds, staying up late, BBQ foods and drinks that might have triggering ingredients…Not to mention the bright flashes and loud bangs of fireworks. Research even shows exposure to sulfur dioxide, a common byproduct of fireworks, may trigger migraine attacks.
If you have migraine and still want to enjoy the holiday, here are some tips from our migraine community: Stay hydrated, wear earplugs, watch fireworks from afar or skip altogether, bring migraine-safe food and drinks to your cookout, wear sunglasses or migraine glasses and keep a consistent routine.
Don't forget to check out AMD's updated triggers page, where you can learn more about common migraine triggers and how to manage them.
Why does fighting migraine stigma matter? That stigma we face may be more harmful than many people realize. Research shows increased stigma is linked with higher disease burden. Molly O'Brien breaks it all down in this Migraine Minute News Update.
Read the study: https://bit.ly/4f8J6wv
Script: June is Migraine and Headache Awareness Month, and you're likely going to hear a lot about fighting migraine stigma. Let's take a look at why it really matters. Stigma is when someone is judged, dismissed, or treated unfairly because of a trait or condition. Through research, we're learning how harmful migraine stigma can be. According to the OVERCOME study, more than 30 percent of those living with migraine said they experience migraine stigma often or very often. The study found that increased migraine stigma was linked with higher disability, more burden between attacks, and lower quality of life, regardless of how many monthly headache days someone has.
Researchers say the social context of migraine might actually have a bigger impact on quality of life than the number of headache days!
With that, fighting stigma and spreading migraine awareness may help better the lives of all of us living with migraine.
A new study shows body pain is more common and widespread in people with migraine or tension-type headache, and may be linked to a greater disease burden. Molly O'Brien breaks down the study in this Migraine Minute News Update.
Read more: https://bit.ly/41BVe10
Script: According to a study published in the Journal of Headache and Pain, body pain is more prevalent and widespread in people with either migraine or tension-type headache.
Researchers in South Korea wanted to better understand the relationship between headache and body pain. They reviewed data from 1,870 people, finding that those with migraine or tension-type headaches reported more body pain than those without.
The location of pain differed between groups. Migraine was linked with neck pain, while tension-type headache showed a link to upper back pain.
The study also found that the more widespread and intense the body pain, the greater the headache burden, including more frequent and severe monthly headache days, lower quality of life, along with more depression, anxiety, and insomnia.
Researchers say the findings may point to central sensitization, where the brain and spinal cord become overly sensitive to pain signals.
According to a study in the New England Journal of Medicine, fremanezumab led to a greater reduction in migraine days per month than placebo in children and adolescents with episodic migraine. Molly O'Brien breaks down the study in this Migraine Minute News Update.
Read the study: https://bit.ly/4csROT5
Script:
In August of 2025, the FDA approved fremanezumab, sold under brand name Ajovy, for prevention of episodic migraine in kids aged 6 to 17 who meet weight requirements. Now we're getting a look at additional research that supports how effective the drug is.
Over the course of three months, 123 young people received a once-per-month injection of fremanezumab, while the other 111 participants got the placebo.
According to the study, published in the New England Journal of Medicine, participants who received fremanezumab had fewer migraine days than those in the placebo group. They also had fewer moderate to severe headache days.
Nearly half of the group taking the treatment saw at least a 50 percent drop in migraine days…
The most common side effect was redness at the injection site. Study authors say a longer follow-up is needed to better understand safety and how well the drug works in kids and teens.
Feeling drained with migraine? New research shows that more than half of people with migraine report fatigue, and it's tied to more frequent attacks and greater disability. Molly O'Brien breaks down the details in this Migraine Minute news update.
Read More: https://bit.ly/4uNcspD
Script:
More than half of people living with migraine say they also struggle with fatigue. That's according to a new study published in BMC's Journal of Headache and Pain.
The study included 2,403 migraine patients, 57 percent of whom reported fatigue.
They also found that people with fatigue had higher migraine frequency, worse sleep more disability, more severe cognitive symptoms, and more symptoms of anxiety and depression, compared to those who didn't.*
Study authors say that because fatigue is so common and impactful in migraine, it needs more attention. They suggested screening should be part of evaluations.
*Although the study did not specify the exact cognitive symptoms, common ones people often experience include brain fog, memory problems, or trouble focusing.
Insurance hurdles like prior authorization and step therapy prevent migraine patients from finding relief, but could payer blocking strategies lead to more ER and hospital visits? Molly O'Brien breaks it down the latest in this Migraine Minute news update.
Read the study: https://bit.ly/40OlvJ0
The Migraine Policy Forum: https://www.linkedin.com/company/the-headache-migraine-policy-forum/
Script:
A study published in Headache shows insurance restrictions that deny access to migraine treatments aren't just frustrating…. These so-called "payer blocking" strategies were linked to more ER visits and hospital stays.
Researchers reviewed information from more than 370,000 people with migraine who were denied access to prescribed migraine drugs at least two times because of payer blocking insurance restrictions like step therapy or prior authorization.
They found payer blocking affected about one in five patients and was more common among those with lower income or lower education levels. They also found people with a history of payer blocking were more likely to visit the ER or be hospitalized for migraine-related or other health issues.
Lead author Dr. Dawn Buse said, "These insurance barriers don't just delay care, they undermine quality of life, especially for those with fewer resources. Reducing them is essential to improving migraine outcomes."
As April is Autism Awareness Month, we're sharing new research on the relationship between migraine and autism. A study published in Headache shows people with autism are more likely to experience migraine or headache, and symptoms may be more severe. Molly O'Brien breaks it down in this Migraine Minute news update.
Read the Study: https://bit.ly/3PyF3P3
Creative Commons: https://creativecommons.org/licenses/by-nc/4.0/
Script:
A study published in Headache found that people with autism are more likely to also have headache or migraine than those without autism.
Looking at two data sets, researchers found that headache and migraine severity were increased in people with autism compared to those without.
Also of note, people with autism and migraine were more likely to have had negative experiences in childhood, such as bullying, being a victim of violence, poor health, anxiety, depression, and concussion.
Researchers note that migraine may be underdiagnosed in those living with autism due to communication barriers and that migraine screening may help with earlier diagnosis and treatment in those with autism.
Facial pain or pressure? It might not be a sinus infection. New findings from AMD's HEADS Registry suggest migraine may be behind these symptoms for some. Molly O'Brien breaks down the research in this Migraine Minute News Update. Read more: https://bit.ly/4aE9Dis Do you have sinus pain, dizziness, or ringing in the ears? The HEADS Registry is collecting patient experiences to improve care.
Learn more: migrainedisorders.org/heads-registry
Creative Commons: https://creativecommons.org/licenses/by/4.0/
Analysis of the COMPEL study shows that onabotulinumtoxinA (Botox) can help reduce migraine days, lower migraine-related disability, and improve quality of life in diverse populations of chronic migraine patients. Molly O'Brien breaks down the data in this Migraine Minute News Update.
Read More: https://bit.ly/4trLxyK
Researchers acknowledge that the term "race" doesn't accurately capture diverse cultural differences, noting that future research should distinguish between race and ethnicity.
*This content is not sponsored and is intended for educational purposes only. It does not constitute an endorsement by the Association of Migraine Disorders for BOTOX® products.
Can vestibular rehab help vestibular migraine? A new review suggests that it may ease dizziness and improve daily functioning. Molly O'Brien breaks down the information in this Migraine Minute News Update.
Read More: https://bit.ly/4aOHo18
Script: A new review published in Headache, The Journal of Head and Face Pain, looked at whether or not vestibular rehabilitation could be effective for vestibular migraine. Researchers looked at seven studies involving more than 400 people with VM. The studies focused on how dizziness affects daily life, using a standardized questionnaire called the Dizziness Handicap Inventory.
Overall, people who did vestibular rehab saw improvements in dizziness and quality of life. Results differed from study to study, so additional research is needed to confirm the benefits and figure out which exercises are most helpful.
Migraine preventive treatment benefits may go beyond fewer headache days. A new study links erenumab to improved symptoms of anxiety, depression, and poor sleep quality in some people with migraine. Molly O'Brien has the details in this Migraine Minute News Update.
Read More: https://bit.ly/3LJl3r7
Script: A new study suggests that one migraine treatment may offer benefits beyond less headache days. Researchers found that the CGRP monoclonal antibody erenumab, sold under the brand name Aimovig, not only reduces migraine frequency… but may improve symptoms of anxiety, depression, and poor sleep quality in some adults with migraine.
Participants took 140MG of erenumab monthly. Over the course of the 24 weeks those who had at least a 50 percent drop in monthly migraine days ALSO saw improved anxiety, depression, and sleep quality. The authors say improvements are likely driven by better migraine control rather than a direct effect of the medication. Researchers also say this study highlights how good migraine prevention may improve overall well-being and quality of life.
In a study published in Headache, researchers identified 36 symptoms that can appear hours before a migraine attack. In this MM news update, Molly O'Brien highlights the most common symptoms, when they occur, and how recognizing these early signs can help people better treat their migraine attacks.
Read more: https://bit.ly/4ozrewr
Transcript:
A new study published in Headache is among the first to explore the migraine prodrome from the patient's perspective.
Researchers held in-depth interviews with 20 people who have migraine, all to better understand what happens before the headache phase begins and how bothersome those symptoms are.
The study identified 36 prodrome symptoms…. with nausea, fatigue, sensitivity to light and sound, neck pain/stiffness, irritability, dizziness or vertigo, sensitivity to temperature, brain fog, and trouble concentrating being the most commonly reported. On average, each participant experienced about 13 prodrome symptoms.
And, 72% of prodrome symptoms occurred one to six hours before the onset of head pain.
The study authors say understanding these early signs may help determine a treatment window…. And if patients can use treatment before severe pain begins, there is potential to reduce migraine burden.
That's your MM news update. I'm Molly O'Brien.
Our recent survey shows some people aren't aware migraine can progress—and many fear their attacks can get worse. Molly O'Brien breaks down the survey results in this MM news update. Do you worry about pain and symptoms getting worse? Let us know in the comments.
Learn more: https://www.migrainedisorders.org/migraine-disorders/migraine-treatments/
Transcript:
Did you know that migraine can be a progressive disease? For some people, attacks can become more frequent, and symptoms or pain may worsen over time. People may even transition from episodic to chronic migraine. The Association of Migraine Disorders held a survey to see how much the migraine community knows about the potential for progression.
Among 459 respondents, 18% did not know that migraine could worsen over time. 50% were aware but hadn't always realized it could progress or become more severe.
68% said they were moderately to extremely worried that their migraine frequency or severity might increase.
While migraine doesn't get worse for everyone, proper treatment can help prevent progression.
If you're nervous about your attacks getting worse, be sure to talk to your healthcare provider and visit AMD's treatments page to learn more.
That's your MM news update, I'm Molly O'Brien.
Treating migraine in pregnancy can be challenging since many drugs carry risks. The good news is that the FDA updated precautions on a drug-free wearable device. Molly O'Brien has the story in this Migraine Minute News Update.
Read More: http://bit.ly/4mMtfo1
Script:
The FDA recently updated its precautionary language on the Nerivio neuromodulation device… removing the note that it has not been studied for use during pregnancy.
Based on a 2023 study published in Headache, the FDA changed the precaution to: "Users should consult their healthcare provider if they are pregnant or intend to get pregnant prior to using the device."
As we previously reported in an August 2023 Migraine Minute News update, the study's results suggest that the Nerivio device is a safe treatment for migraine during pregnancy, does not increase the risk for adverse pregnancy outcomes, and may offer a drug-free treatment option for migraine during pregnancy.
First-of-its-kind study: A new study suggests that a combination of THC + CBD works better than placebo, THC alone, or CBD alone for reducing migraine pain and symptoms. Molly O'Brien breaks it down in this Migraine Minute News Update.
Read More: https://bit.ly/4qvpuWo
Script: For the first time, researchers tested cannabis in a placebo-controlled trial for migraine… and results suggest it could be effective. A recent study found that when treating migraine attacks, a vaporized combination of THC and CBD worked better than THC alone, CBD alone, or a placebo. THC alone helped with pain, but not other symptoms, while CBD alone did not show any benefit.
Study participants who used the THC/CBD combination also saw improvements in light and sound sensitivity, but not nausea or vomiting.
No serious adverse events were reported.
In an interview with MedScape, one researcher noted that people experienced benefits without using higher, recreational doses of cannabis.
A new real-world study shows atogepant (sold under brand name Qulipta) may quickly reduce migraine days—even for those who haven't responded to other treatments. Molly O'Brien has more in this Migraine Minute News Update!
Read more: http://bit.ly/3UcEuJN CC License: https://creativecommons.org/licenses/by-nc-nd/4.0/ Script: The GIANT study, published inThe Journal of Headache and Pain, offers real-world evidence that atogepant is a safe, well-tolerated, and effective for migraine prevention—among those whose prior treatments didn't work.
Researchers looked at the impact of 60 mg of atogepant, taken once daily in people with either high-frequency episodic or chronic migraine. Many of the participants had already tried at least three other preventive treatments… including CGRP monoclonal antibodies.
Results? At 12 weeks, on average, participants saw a decrease of 6 migraine days and 11 headache days per month. In fact, nearly 60% of experienced at least a 50 percent drop in migraine days. Pain intensity, disability, and use of acute drugs also dropped.
Some saw improvement in migraine frequency within the first week.
Can diabetes and weight loss drugs help with migraine relief? A new study suggests GLP-1 medications may significantly reduce migraine days. @ Molly O’Brien has more in this Migraine Minute News Update.
Read More: http://bit.ly/4kGN4eO
Image and license to use: Headache. 2025; 00: 1-8. http://bit.ly/47imNQO
Script: GLP-1s….a drug class widely used for diabetes and weight loss treatment, may also help migraine.
A small study published in Headache looked at liraglutide as an add-on treatment for unresponsive migraine in people with obesity who have tried at least two preventive migraine treatments. The study tracked 31 adults with high-frequency episodic or chronic migraine.
After taking a daily dose of the drug for three months, on average, they saw monthly headache days drop from about 20 to just under 11—a significant improvement. What may be surprising… is that the benefit came with insignificant weight loss.
A major study found that oral triptans work better for the acute treatment of migraine, than newer drugs. Molly O’Brien breaks it all down in this Migraine Minute News Update.
Read more: https://bit.ly/3Wu6ZnP
Images and License to use: BMJ 2024;386:e080107http://bit.ly/4ljgU9x
Script: A major international study published in the British Medical Journal found triptans to be the most effective acute treatment for migraine.
Researchers analyzed 137 clinical trials involving nearly 90,000 adults… comparing 17 oral treatments. They looked at how many people were pain-free two hours post-dose and how many were still pain-free at 24 hours, as well as the safety and tolerability of the treatments.
They looked at how many people were pain-free at 2 hours and 24 hours, as well as the safety and tolerability of the treatments.
The top performer? Eletriptan — it was shown to be the most effective for both rapid and sustained pain relief. Other high performers included rizatriptan, sumatriptan, and zolmitriptan. Those four triptans consistently outperformed newer acute treatment options like lasmiditan, ubrogepant, and rimegepant.
These newer acute treatments worked about as well as acetaminophen and most non-steroidal anti-inflammatory drugs. Also, results showed that not all NSAIDs work the same for migraine.
A study in the Journal of Psychopharmacology found a surprising connection between psychedelic use and frequent bad headaches. Could psilocybin play a role in headache treatment? Molly O’Brien explains in this Migraine Minute News Update. Read more: http://bit.ly/40k21Mu
Script:
A new study in the Journal of Psychopharmacology shows that people who’ve used psychedelics like LSD or psilocybin may be less likely to experience frequent bad headaches.
Researchers analyzed data from a large group of people in the UK and found that those who reported a lifetime use of classic psychedelics were 25% less likely to report frequent bad headaches compared to those who had never used them.
So why might that be? One thought is that both psychedelics and conventional migraine drugs (like triptans) work on serotonin receptors in the brain.
While the study doesn’t prove that psychedelics directly prevent headaches, It DOES add to growing evidence that psychedelics may be a helpful tool to treat headache disorders. And a quick note, psychedelics are illegal on a federal level in the US. That’s your migraine minute news update, I’m Molly O’Brien.
Images: Sage Journals. The Journal of Psychopharmacology. doi: 10.1177/02698811251324
License to use: https://creativecommons.org/licenses/by/4.0/
Scientists are learning how stress may trigger a series of brain responses that could be linked to migraine, at least in mice. Molly O’Brien has more in this Migraine Minute News Update.
Source: PACAP38/mast-cell-specific receptor axis mediates repetitive stress-induced headache in mice
Script: A study published in the Journal of Headache and Pain explains how stress can lead to migraine pain. Research in mice found that stress increases a brain chemical called PACAP-38. This chemical activates specific cells that release inflammatory substances. This series of events can affect the trigeminovascular system, which may trigger migraine pain.
The study’s author notes that blocking or interrupting this pathway could offer a new way to treat or prevent migraine attacks.
Two innovative DHE-based migraine treatments just earned FDA approval—offering some Americans new options for managing attacks. Molly O’Brien has details in this #MigraineMinute News Update.
Read More: https://bit.ly/4kgmXMt and https://bit.ly/3SYet0c
*DHE is not safe for the management of hemiplegic migraine, migraine with brainstem aura, in people with certain comorbidities, or in those who take certain medications.
Script: Many Americans with migraine now have two new treatment options, thanks to recent FDA approvals of Brekiya and Atzumi. Both drugs utilize Dihydroergotamine or DHE.
While DHE for migraine has been around for decades, these two new drugs have new delivery methods.
Brekiya is the first and only DHE auto-injector approved for the acute treatment of migraine and cluster headache in adults.
Atzumi is the first and only DHE nasal powder approved for the acute treatment of migraine with or without aura in adults.
It’s important to note that DHE has several safety implications and contraindications and must be prescribed by a healthcare provider.
Celebrating the Fourth of July with migraine is not easy. The holiday can be packed with sensory overload and migraine triggers. In this Migraine Minute, Molly O’Brien shares tips to help you enjoy the celebration while protecting your health. Check out our updated triggers webpage: https://bit.ly/4kFOZRf
Reference: https://pubmed.ncbi.nlm.nih.gov/19329386/ Script: While the Fourth of July can be a fun holiday to celebrate in the States, it can be tough for folks with migraine. Why? Well, there are so many factors that can be stacked against you. Think about it, heat, big crowds, staying up late, BBQ foods and drinks that might have triggering ingredients…Not to mention the bright flashes and loud bangs of fireworks. Research even shows exposure to sulfur dioxide, a common byproduct of fireworks, may trigger migraine attacks. If you have migraine and still want to enjoy the holiday, here are some tips from our migraine community: Stay hydrated, wear ear plugs, watch fireworks from afar or skip all together, bring migraine safe food and drinks to your cook out, wear sunglasses or migraine glasses, and keep a consistent routine.
Don’t forget to check out AMD’s updated triggers page, where you can learn more about common migraine triggers and how to manage them.
New research shows CGRP monoclonal antibody treatment may not prevent migraine attacks triggered by the neuropeptide PACAP-38. This study suggests PACAP-38 may act through a different pathway and could become a future preventive option for people who don’t respond to CGRP-based treatments. Molly O’Brien explains in this Migraine Minute News Update.
Read More: https://bit.ly/4ivy3LG
Images courtesy: Springer Nature. The Journal of Headache and Pain. doi: 10.1186/s10194-025-02022-2 Creative Commons license: https://creativecommons.org/licenses/by-nc-nd/4.0/ Script:
Does PACAP 38 Work Differently Than CGRP?
A new study published in the Journal of Headache and Pain found that migraine attacks can be triggered by the neuropeptide PACAP-38 despite pre-treatment with a CGRP monoclonal antibody.
Researchers gave 38 participants with migraine an infusion of eptinezumab—a CGRP monoclonal antibody—or placebo, followed by PACAP-38. The results showed no difference in the incidence of migraine attacks between the two groups.
This study suggests that PACAP-38 may trigger migraine attacks through a different pathway than CGRP. Treatments targeting PACAP-38 may offer a new preventive option for people who’ve had limited or no success with CGRP monoclonal antibodies.
A study published in JAMA Neurology shows that monthly erenumab injections may help treat medication overuse headache (MOH) in people with chronic migraine. While the 140 mg dose was effective for treating MOH, the 70 mg dose did not show a meaningful difference compared to placebo.
Molly O’Brien explains in this Migraine Minute News Update.
Read More: https://bit.ly/4jCusxk
Image Courtesy: JAMA Neurology doi:10.1001/jamaneurol.2024.3043 Transcript: A study published in JAMA Neurology looked at the safety and efficacy of a CGRP monoclonal antibody for treating Medication Overuse Headache in people with chronic migraine. Results show that erenumab– sold under brand name Aimovig- can lead to lasting remission of MOH, reduce the need for pain medication, and improve daily functioning over six months. The study included 584 people with chronic migraine who also had medication overuse headache. At 6 months, 69.1% of those who received 140 mg injections of erenumab monthly no longer met the criteria for medication overuse headache compared to 52.6% of people in the placebo group. It should be noted that the study did not include people who had medication-overuse headache from opioid use.
Most people with migraine go through trial and error to find a preventive treatment that works. But researchers at the Mayo Clinic may have found a way to change that. Using AI, they developed a tool to predict how someone might respond to certain migraine medications—particularly CGRP monoclonal antibodies.
Molly O’Brien has more in this Migraine Minute News Update.
Read More: https://bit.ly/40uKyjE
Rapid relief from a preventive migraine treatment? A study published in Neurology shows that one oral gepant medication may start working right away to prevent migraine attacks. Molly O’Brien fills you in, in this Migraine Minute News Update.
Read more: https://bit.ly/3Wvb1fU
The FDA has approved a new drug for the acute treatment of migraine with or without aura in adults. Molly O’Brien has the details and when it becomes available in this Migraine Minute News update.
Learn More: https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-announces-fda-approval-symbravor-meloxicam
Researchers in Boston found that CGRP-blocking drugs commonly used for migraine may help with endometriosis pain and lesion size. Molly O’Brien has the details in this Migraine Minute news update recognizing Endometriosis Awareness Month.
Read More: https://bit.ly/4jp0cG2
AMD Comorbidities Library: https://bit.ly/3CIrLtd
Cluster Headache Awareness Day is March 21st. In this Migraine Minute News Update Molly O’Brien explains findings from a study that found cluster headache, fibromyalgia, and migraine are frequently comorbid conditions.
Learn More: https://bit.ly/42pSNQS
According to a study published in Neurology, when compared to placebo, this gepant led to significantly greater ability to function normally and a greater reduction in activity limitation when taken during the prodrome phase of an attack.
Molly O’Brien has the details in this Migraine Minute News Update.
Read More: https://bit.ly/3BY2J9d
Kids age 8+ now have access to a non-drug migraine treatment option. In this Migraine Minute News Update, Molly O’Brien explains the FDA clearance of Theranica’s Nerivio device for acute and preventive migraine treatment in kids. Read more: https://bit.ly/4fRXRk5
Researchers have identified elevated levels of the gene MERTK, (which is linked to cluster headaches) and its ligand Gal-3, in the nerve tissues of rats and in blood samples of people with cluster headache.
In this Migraine Minute News Update Molly O’Brien breaks down what it means for people living with Cluster.
Read More: https://bit.ly/3ZXzTQ0
Contrary to previous research, a study published in Neurology finds among women, there is no link between migraine and the risk of developing Parkinson’s disease. Molly O’Brien explains in this Migraine Minute News Update.
Want to know more about Migraine and Parkinson’s disease? Check out this article in AMD’s Comorbidities library https://bit.ly/3XZSaJB
A small study published in the New England Journal of Medicine finds a single IV infusion of a Monoclonal Antibody targeting PACAP reduced monthly migraine days better than placebo.
In this Migraine Minute News Update @Molly O’Brien explains.
Read More: https://bit.ly/3XXXNrR
The National Institute of Neurological Disorders and Stroke awards a $2.4 million grant to researchers at the University of Texas Health to examine the link between the circadian clock and severe headache disorders. Molly O’Brien has details in this Migraine Minute News Update.
Read more: bit.ly/3BsNwfT
A study finds treatment with anti-CGRP mAbs does not significantly affect blood pressure or increase the occurrence of hypertension (compared to general population trends) in people 60+. In this Migraine Minute, Molly O’Brien explains the findings.
Read More: bit.ly/3zpcYSB
A study found that anti-CGRP monoclonal antibodies not only reduced absenteeism & presenteeism in Spain, they were found to be cost-effective too.
Read more: http://bit.ly/3S1KS5Y
Image courtesy: DOI 10.1186/s10194-024-01727-0
A new study looks at the efficacy and safety of two gepant medications. Molly O'Brien will share the study findings in this Migraine Minute News update.
Read the study: bit.ly/4cwJQar
Image courtesy: Sage Journals. Cephalalgia doi:10.1177/03331024241235156
Light sensitivity and poor sleep quality in people with migraine, could the two be related? In a study published in the Journal of Headache and Pain, researchers looked at the impact photophobia may have on sleep quality in people with migraine. Molly O’Brien breaks it down in this Migraine Minute News Update.
Learn more: bit.ly/4cIJMUD
Caffeine habit? A new study looks at the link between episodic migraine and regular caffeine intake. Molly O’Brien will fill you in, in this latest Migraine Minute News Update.
Learn more about the study at bit.ly/4bzLyXu
The US FDA clears another wearable drug-free migraine treatment device. In this Migraine Minute News Update, Molly O’Brien will tell you all about a new TENS device available for people with episodic migraine.
Read more: https://bit.ly/4aEZFe9
Many people with chronic migraine worry that their monthly preventive medication won’t work as well at the end of the month as it did at the beginning. New research shows that two injectable CGRP monoclonal antibodies do not wear off at the end of the month.
Molly O’Brien has the details in this #MigraineMinute News Update.
Read more: bit.ly/3w95WQn
A study in the Lancet found one oral gepant to be safe and effective in people with episodic migraine who have failed two to four classes of preventive treatments. Molly O’Brien explains in this Migraine Minute News Update. Read the study here: https://bit.ly/3w3ZM45
A new study looks at real-word effectiveness of Anti-CGRP monoclonal antibodies & OnabotulinumtoxinA for chronic migraine. Molly O'Brien will share the study findings in this Migraine Minute News update. Read the study: https://bit.ly/4d1mPx1
*The graphic used in this content is courtesy of Grazzi, L., Giossi, R., Montisano, D.A. et al. Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study. J Headache Pain 25, 14 (2024). https://doi.org/10.1186/s10194-024-01721-6. The graphical abstract has been slightly modified.
Researchers at the University of California Los Angeles found changes in blood flow in the retina might explain why some people have visual migraine symptoms. Molly O'Brien has the details in this Migraine Minute News update.
Learn more: https://bit.ly/3xou7uw , https://bit.ly/4aErYZN
AMD is thrilled to share what we’ve learned so far from our HEADS Registry! Molly O'Brien goes over the exclusive new data in this Migraine Minute News Update. The HEADS Registry serves as a crucial resource for researchers and clinicians. It’s not too late to share your experience, by doing so, you can help pave the way for more effective therapies, enhanced and personalized patient care, and improved quality of life. Learn more at migrainedisorders.org/heads-registry/
Obesity is often connected with an increase in migraine frequency, severity and disability.
In this Migraine Minute News Update, Molly O'Brien gives details on what we’re learning about one MAB drug and its effectiveness in people with migraine and comorbid obesity.
Read more here: https://bit.ly/3ONRu6m
New results from the OVERCOME study, published in Neurology, Found that just over 31 percent of people living with migraine often or very often feel stigmatized. Molly O'Brien will fill you in on the details in this Migraine Minute News Update.
Nerivio becomes the first drug-free Migraine Treatment to Receive Commercial Insurance Coverage in the US. Molly O'Brien explains in this Migraine Minute News Update. Read more here: https://bit.ly/3T6lKvL
We know Migraine and ADHD are comorbid, but there is still a lot left to learn about how they are connected. @Molly O’Brien will fill you in on new research that explores ADHD symptoms in people with migraine.
Sources: https://bit.ly/3vNm6hT
Second hand smoke can often be a trigger for people with migraine, but is there a connection between how much exposure someone has to second hand smoke and migraine disease? Molly O'Brien talks about the latest research in this Migraine Minute News Update. Read the full story: https://bit.ly/3vE2MDD
Feel a migraine attack coming on? New research shows these three types of medications may be more effective than ibuprofen for many people.
Molly O’Brien will share details in this Migraine Minute News Update.
Read more here: https://bit.ly/47HEwh9
New research shows taking one type of gepant medication during the prodrome phase may reduce the risk of a severe headache.
Molly O’Brien will fill you in, in this Migraine Minute News Update.
Read the study here: https://bit.ly/3GLKEtT
Are you looking for new ways to manage migraine in the new year? Practicing mindfulness may help.
Molly O’Brien explains in this Migraine Minute News Update.
More info: https://bit.ly/3RRdVd1
Singer and actress Ally Brooke Hernandez rose to international fame as a member of the all-female singing group Fifth Harmony. In an interview with People en Espanol, Hernandez spoke out about how migraine has impacted her life and career. Molly O’Brien will fill you in on this Migraine Minute News Update.
Read the full story: https://bit.ly/3FG2Q7s
As we honor and celebrate those who have and continue to serve our country on Veterans Day, the Association of Migraine Disorders wants to raise awareness about how headache disorders affect those who serve. To our brave service members, thank you.
Learn more about how headache impacts Veterans and services the VA offers:
https://bit.ly/45Y94dC
https://bit.ly/3FG37r0
A new survey shows Nerivio may be a safe treatment option during pregnancy. Molly O’Brien with the Association of Migraine Disorders will fill you in with the latest Migraine Minute News Update. For more information and full details about the study check out this link:
https://bit.ly/3EQ2lHE
The Headache, Ear, Auditory, Dizziness, Sinus (HEADS) Registry is a new research initiative launched by the Association of Migraine Disorders. The HEADS Registry captures information about people who have sinus, vestibular, and auditory symptoms. In this Migraine Minute News Update Molly O’Brien will explain how your experiences can help advance research. Get more information and a link to sign up for the HEADS Registry here:https://www.migrainedisorders.org/heads-registry/
New research shows that botulinum toxin treatments for migraine in adolescents may be more effective than past studies state. Molly O’Brien will fill you in on the latest in this week’s Migraine Minute News Update. For more information: https://www.sciencedirect.com/science/article/abs/pii/S0887899423002138
A Dutch medical device company announces its first clinical trial of an implanted neuromodulation device to help treat migraine and cluster headache. MollyO’Brien has the latest in this Migraine Minute News Update.
The American Heart Association has awarded 2.1 million dollars to research the link between migraine, stroke, and heart disease. Molly O’Brien will fill you in with the latest Migraine Minute News Update.
For more information and the full story check out this link: https://bit.ly/45wOqSx
Caffeine! Researchers continue to learn more about how caffeine can impact people with migraine. Molly O’Brien will fill you in with the latest Migraine Minute News Update.
Follow @migrainedisorders to catch these updates.
For more information and full details about the study check out this link: https://go.nature.com/44jRO28
In a recent interview with Insider, #Olympic #gymnastics champion #AlyRaisman opens up about her life with #migraine and why pushing through the pain wasn’t healthy. Molly O’Brien will fill you in on the latest in this week’s Migraine Minute News Update. Follow @migrainedisorders.
Read the full story: https://bit.ly/3NSGcxC
Do you have more migraine attacks in the summer? Changes in weather, barometric pressure, and upended schedules could be part of the reason why. Molly O’Brien will fill you in with the latest Migraine Minute News Update.
Follow @migrainedisorders to catch these updates.
For more information and the full story check out this link: https://mayocl.in/442HfAZ
A new study published in the Journal of Medical Economics shows that using Nerivio can lead to big cost savings when used as a preventative treatment.
For more information and full details about the study read the article using the link: https://bit.ly/42Y8j3
A recent article looks at the possible benefits of using venlafaxine to help with vestibular migraine. The article states that much like other drugs, venlafaxine did not reduce the function (restrictions, difficulties, avoidances) or physical aspects of VM (which activities exacerbate the problem). It did, although help with the emotional aspects of VM–like feelings of frustration, anger, embarrassment, worry. Molly O’Brien will catch you up in the latest Migraine Minute News Update.
Follow @migrainedisorders.
More info: https://bit.ly/45cmS
It’s commonly known that migraine and endometriosis are comorbid– but information on the differences in symptoms and severity of endometriosis in people with migraine is still lacking. Researchers are learning more about how the two are linked. Molly O’Brien will catch you up in the latest Migraine Minute News Update.
Follow @migrainedisorders.
More Info: https://bit.ly/3Mx9L7j
What do we know about the safety of onabotulinumtoxinA injections for migraine during pregnancy? Molly O’Brien will fill you in on the latest in this week’s Migraine Minute News Update. Follow @migrainedisorders. More info: https://bit.ly/3Md2fwY
Do you usually experience migraine attacks on the left or right side of your head? Scientists found differences in migraine on each side! Molly O’Brien will fill you in with the latest Migraine Minute News Update. Follow @migrainedisorders to catch every update. For more information and full details about the study check out this link: https://bit.ly/3IivcXj
Do you get migraine or cluster attacks around the same time of day? New research shows that isn’t a coincidence! Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Follow @migrainedisorders to catch these updates.
More info: https://www.uth.edu/news/story/cluster-headache-migraine-strongly-associated-with-circadian-system-according-to-published-research
The FDA approves a new prevention therapy for chronic migraine. @Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Follow @migrainedisorders to catch these updates.
More info:
https://news.abbvie.com/news/press-releases/us-fda-approves-qulipta-atogepant-for-adults-with-chronic-migraine.htm
Do you have trouble talking or focusing during a migraine attack? You’re not alone. Molly O’Brien will get you caught up on the latest migraine news in this Migraine Minute News Update. Follow @migrainedisorders.
More info:
https://bit.ly/3zIaHi9
https://bit.ly/3GUoVk3
What do we know about smoking cigarettes and migraine? Molly O’Brien will get you caught up on the latest migraine news in this Migraine Minute News Update. Follow @migrainedisorders.
More info:
https://bit.ly/3zti4Kh
https://bit.ly/40lL8yR
https://bit.ly/3FWqCN2
Alert New acute and preventative #migraine treatment options! Molly O’Brien will get you caught up in this Migraine Minute News Update. Follow @migrainedisorders for the latest in migraine.
More info: https://bit.ly/3JCjx6M https://bit.ly/3YPGLKZ https://bit.ly/3TfGeAQ MigraineDisorders.org
What’s the relationship between migraine and anxiety? Molly O’Brien will fill you in on that and the latest on a migraine drug in the pipeline.
More info:
https://bit.ly/3xXLoHS
https://www.migrainedisorders.org/the-link-between-migraine-and-anxiety/
www.MigraineDisorders.org
Can history of migraine be an indicator of pregnancy complications? Molly O’Brien will fill you in on the latest migraine news in this Migraine Minute News Update.
More info:
https://bit.ly/3HD6L5K
https://bit.ly/3YvdwNC
https://go.nature.com/3YBMbcY
https://bit.ly/3xczxVO
https://www.migrainedisorders.org/education/patient-resources/videos/
MigraineDisorders.org
Are nerve blocks a good migraine treatment option? What’s the connection between ADHD and migraine? Molly O’Brien will fill you in on the latest migraine news in this Migraine Minute News Update. Catch episodes by following @migrainedisorders.
More info:
https://bit.ly/3iWd9wN
https://bit.ly/3WVCCFm
https://www.migrainedisorders.org/migraine-and-adhd/
MigraineDisorders.org
New data on ubrogepant --and what can Twitter teach us about migraine? Molly O’Brien fills you in on the latest migraine news. #MigraineMinute More info:
MigraineDisorders.org
https://bit.ly/3Mw3UMU
https://bit.ly/3MA69yN
https://bit.ly/3KhetBP
Can brain tissue from mice lead to new migraine treatments? Molly O’Brien will fill you in on the latest migraine news in this Migraine Minute. More info:
MigraineDisorders.org
https://bit.ly/378hEyn
https://bit.ly/3xmn3fD
https://www.getrootlogic.com
The largest genetic study of migraine reveals new genetic risk factors. Molly O’Brien will fill you in on the latest #migraine news in this week’s Migraine Minute. More info:
https://www.eurekalert.org/news-releases/942272
https://www.pediatricmigrainestudy.com
https://www.getrootlogic.com
A new treatment for chronic migraine prevention could be coming soon. Molly O'Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Source:
https://bit.ly/35UdDwJ
https://bit.ly/3MNtf5Q
https://bit.ly/36lT1xe
https://brainawareness.org
#migraine #migraineresearch #migrainetreatment #headache #headaches #CGRP #drugtrial #clinicaltrials #health #healthnews #migrainenews #womenshealth #migraineattack #headachedisease #migraines #news #vestibularmigraine #posttraumaticheadache #migrainetherapy
Are women with migraine at greater risk for complications during pregnancy? Learn about a new drug for acute migraine. Molly O'Brien will fill you in on the latest migraine news in this week’s #MigraineMinute. More info:
https://bit.ly/3IGDtma
https://wb.md/3vwe0rN
https://bit.ly/3pyYAiK
MigraineDisorders.org
#migraine #migraines #migraineawareness #migrainerelief #migrainewarrior #pregnancy #hormones #womenshealth #health #healthnews #research #migraineresearch #migrainetreatment #drug #migrainedrug #Nurtec #Biohaven #Elyxyb #CGRP
New insight on the link between genetics and migraine could open the door to new treatments. Molly O’Brien fills you in on the latest news in this Migraine Minute. Follow @migrainedisorders to catch updates. More info:
https://go.nature.com/3LMOUdY
https://bit.ly/3sNeDu9
https://bit.ly/3oVlHU9
MigraineDisorders.org
Can vitamin D help migraine? Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week More info:
https://bit.ly/347caSI
https://bit.ly/3ucAVrs
https://bit.ly/3ohp0Vt
MigraineDisorders.org
The Association of Migraine Disorders backs new recommendations to improve care in Vestibular Migraine. Molly O’Brien will fill you in on the latest migraine news in this Migraine Minute. Follow @migrainedisorders
More info:
https://bit.ly/3rr9Xt1
https://wb.md/3tADjYB
https://wb.md/3qzIm9J
https://www.migrainedisorders.org
A new study looks at the impact of COVID-19 quarantine on migraine. And what were the hottest migraine topics in 2021? Molly O'Brien will fill you in on the latest migraine news in this #MigraineMinute.
*Content was recorded before the new year
More info: https://bit.ly/3qGhRyx
https://bit.ly/3Jsw76l
https://www.migrainedisorders.org
Can a common spice help treat migraine symptoms? Molly O'Brien will fill you in on the latest migraine news in this #MigraineMinute. More info: https://bit.ly/3E3qLuD https://bit.ly/3yvWdjK https://www.migrainedisorders.org
Results from a new drug trial show migraine pain relief for some in as little as 15 minutes. Molly O’Brien will fill you in on the latest migraine news in this Migraine Minute. Follow @migrainedisorders
More info:
https://bit.ly/3oxaM3k
https://yhoo.it/307VVmt
https://www.migrainedisorders.org
#migraine #migraineattack #migraineheadache #headache #chronicpain #womenshealth #migrainewarrior#migraineminute #migrainenews #healthnews #health #research #migrainedisorders #migrainedisease #womenshealth#Covid19
One CGRP inhibitor goes head to head with a traditional migraine preventative in a new study. @MollyjoOBrien will fill you in on the latest migraine news in this #MigraineMinute. More info: https://bit.ly/3CzB3Sf https://www.migrainedisorders.org/researchishope/ https://www.withcove.com #migraine
New research out on the migraine- sleep connection. Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Follow @migrainedisorders to catch these updates every week
More info:
MigraineDisorders.org
https://bit.ly/3DeRzrN
https://prn.to/3l973Hv
https://www.migraineshields.com
We’re learning more about how COVID-19 affects people with migraine. Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Follow @migrainedisorders to catch these updates every week
More info:
MigraineDisorders.org
https://bit.ly/3F5jFYf
https://bit.ly/3F1AVgN
https://www.migraineshields.com
#migraine #migraineattack #migraineheadache #headache #chronicpain #womenshealth #migrainewarrior#migraineminute #migrainenews #healthnews #health #research #migrainedisorders #migrainedisease #womenshealth
A new treatment becomes available for two rare & painful headache disorders. Molly O'Brien will fill you in on the latest in this week’s #MigraineMinute. More info: MigraineDisorders.org https://bit.ly/3EBUkF3 https://bit.ly/3CBCnV7 juli.co/migraine
Combining acupuncture with a triptan could provide better migraine relief. Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week
More info:
MigraineSymposium.Org
https://bit.ly/3tO4a1C
https://bit.ly/3hv2gOc
A new migraine treatment gets FDA approval. When will it be available? Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week
More info:
MigraineDisorders.org
https://bit.ly/3nn724o
https://bit.ly/3lcErff
https://www.juli.co/migraine
Positive results in a trial of a new migraine prevention treatment-- Molly O’Brien will fill you in on the latest migraine news in this Migraine Minute. Follow @migrainedisorders to catch these updates every week.
More info:
MigraineDisorders.org
https://bit.ly/3jd02oa
https://bit.ly/3klSAGI
theraspecs.com
A potential new treatment option for those living with menstrual migraine. Molly O'Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Follow Association of Migraine Disorders to catch these weekly updates. More info: MigraineDisorders.org https://bit.ly/3k4jnHm https://bit.ly/37RNQCE https://www.migrainedisorders.org/migraine-symposium-2021/ #migraine #migraineattack #migraineheadache #headache #chronicpain #womenshealth #migrainewarrior #migraineminute #migrainenews #healthnews #health #research #migrainedisorders #migrainedisease
Stark racial & socioeconomic disparities exist in diagnosing & treating headaches. Molly O’Brien will fill you in on the latest migraine news in this #MigraineMinute More info: MigraineDisorders.org https://bit.ly/2U2Yinx https://bit.ly/3lIXRKJ theraspecs.com
Could one type of B vitamin help prevent migraine? Molly O’Brien will fill you in on the latest in this week’s Migraine Minute. Follow @migrainedisorders to catch weekly updates.
Sensory Alert For those with sound sensitivity, there is a dog bark at end of the video
More info:
MigraineDisorders.org
https://bit.ly/3xqnqCe
https://bit.ly/3xmh9rd
https://bit.ly/3ipbsVk
Don't forget the AMD Virtual Symposium is Sept. 17-18. Use code MigraineMinute to get 50% off your ticket!
What can a VR roller coaster ride tell us about migraine? Molly O'Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week More info: MigraineDisorders.org https://bit.ly/2TzZrTk https://bit.ly/3eWEx8k https://bit.ly/3eV4mFN
Is one type of nerve block more effective for treating a migraine attack than others? Molly O’Brien will fill you in on the latest migraine news in this Migraine Minute. Follow @migrainedisorders to catch these updates every week
More info:
MigraineDisorders.org
https://bit.ly/3wSsbo2
https://bit.ly/2UZzsFg
https://bit.ly/3rndHey
Could eating more fatty fish reduce migraine pain? Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week
More info:
MigraineDisorders.org
https://bit.ly/2T46hjK
https://bit.ly/3wFpSoa
https://prn.to/3AXAKkM
#migraine #migraineattack #migrainehealth #healthnews #migrainenews #migraineminute #womenshealth#migrainenutrition #wellness #pediatricmigraine #kidshealth #migraineresearch #headache #headaches#migrainetreatment
Can Eptinezumab be effective if given during a migraine attack?
Molly O’Brien will fill you in on the latest migraine news in this Migraine Minute. Follow @migrainedisorders to catch weekly updates.
More info:
MigraineDisorders.org
https://bit.ly/35I2RWL
https://bit.ly/2TVkK1w
shadesformigraine.Org
Are migraine patients more resilient in handling traumatic stress? Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week
More info:
MigraineDisorders.org
https://bit.ly/3iKTj4O
https://bit.ly/3vw1F39
https://shadesformigraine.org
Can acupuncture help improve cognitive function in migraine patients? Molly O’Brien fills you in! Don’t miss Migraine Minute--Follow @migrainedisorders to catch weekly updates.
More info:
MigraineDisorders.org
https://bit.ly/3x9Vhj4
https://bit.ly/2Sj05UI
Shadesformigraine.org
Nurtec becomes the first & only medication approved to treat & prevent migraine attacks. Molly O’Brien fills you in! Don’t miss Migraine Minute--Follow @migrainedisorders to catch weekly updates.
More info:
MigraineDisorders.org
https://bit.ly/3wTO3zT
https://bit.ly/3yWn48s
https://shadesformigraine.org
A new clinical trial underway is the first to examine THC and CBD as potential migraine treatments. Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Follow @migrainedisorders to catch these updates every week. More info:
MigraineDisorders.org
https://bit.ly/2SteD3N https://bit.ly/3hUnO84
https://www.migraineheadacheawarenessmonth.org/blog/
Researchers may be closer to finding out the cause of migraine with aura. Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Follow @migrainedisorders to catch these updates every week
More info:
MigraineDisorders.org
https://bit.ly/2QzRfBa
https://bit.ly/3tZ7Hsd
ShadesForMigraine.org
A three-time Olympic gold medal winner shares their migraine story. Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Follow @migrainedisorders to catch these updates every week
More info:
MigraineDisorders.org
https://bit.ly/3bijCuI
https://bit.ly/3w6ZgNb
ShadesForMigraine.org
AMD is celebrating Mother’s Day with our Strong As A Mother Research Is Hope Campaign. This week’s stories are focused on women and moms impacted by migraine disease. Follow @migrainedisorders to catch weekly updates.
More info:
MigraineDisorders.org
https://mayocl.in/3h0m0de
https://bit.ly/33j2Ua0
Headache doctor's prescribing apps for migraine treatment? Molly O'Brien will fill you in on this week's Migraine Minute. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week! More info: MigraineDisorders.org https://bit.ly/3vpokyp https://bit.ly/3tZDBWf https://bit.ly/3evhDnG
Are hallucinations linked to migraine? Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week
More info:
MigraineDisorders.org
https://wb.md/3dxzDhQ
https://bit.ly/32unnZl
https://bit.ly/3apmsh0
Do typical migraine treatments impact COVID-19 vaccine immune response? Molly
O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week
More info:
MigraineDisorders.org
https://bit.ly/3e7V5Jh
https://bit.ly/2Q6OSFx
https://bit.ly/2ORDyN7
Can wet cupping therapy help headache severity? Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week!
More info:
https://bit.ly/3d2SEbY
https://bit.ly/3dNcXcm
https://bit.ly/3wD942d
A new study finds one ER treatment to help acute post-traumatic headache….Molly O’Brien will fill you in on that and more in this week’s Migraine Minute News Update. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week!
https://bit.ly/31wPLtk
https://bit.ly/31BySO0
https://bit.ly/3dlg1w5
Carnitine supplements and telehealth for migraine--Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week!
https://bit.ly/3rhh7xN
https://bit.ly/3cfRbOV
https://bit.ly/3sk7Eav
How does estrogen impact migraine? Endorphins to treat migraine pain? Molly O’Brien will fill you in on that and more in this week’s Migraine Minute News Update. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week!
https://bit.ly/3bUVpeI
https://bit.ly/30SLobO
https://bit.ly/38O7JM0
The FDA cleared a new neuromodulation device for acute migraine treatment. Molly O’Brien will fill you in on that and more in this week’s Migraine Minute News Update. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week!
https://bit.ly/3l4fF0y
https://bit.ly/38qpkcC
https://bwnews.pr/38psrBy
Do migraine patients feel better during COVID lockdowns? Can cannabis use lead to medication overuse headache? Molly O’Brien will fill you in on that and more in this week’s Migraine Minute News Update. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week!
More info:
https://bit.ly/3e6hqsB
https://go.nature.com/2PupZD3
https://wb.md/3qhZfCL
What migraine treatment options are available during pregnancy and postpartum? Can the right amount of exercise help with migraine? Molly O’Brien will fill you in on that and more in this week’s Migraine Minute News Update. Never want to miss an episode? Follow @migrainedisorders to catch these updates every week!
More info on the stories discussed:
https://bit.ly/2NwScJ7
https://bit.ly/3bCmVMJ
https://bit.ly/3dZkerx
#migraine #migraineheadache #migraineattack #pregnancy #migraineandpregnancy #postpartum #migrainetreatment #exercise #dizziness #headache #research #neuroscience
What role do pharmacists have in counseling people on migraine treatments? Molly O'Brien will fill you in on that and new research on migraine treatments. Catch this week’s Migraine Minute News Update, follow Association of Migraine Disorders to never miss an episode. More info on stories we discussed: https://bit.ly/37mt7qR https://bit.ly/2NuZnkt https://bit.ly/2OIo8u1 #migraine #migraineattack #migrainenews #migraineresearch #migraineheadache #headache #dizziness #nausea #migrainesymptoms #health #healthnews #wellness #migrainetreatment #headaches #pharmacist #pharmacy
Could rimegepant be effective for migraine prevention? Are prescription drug prices higher in the United States? Molly O’Brien will fill you in on that and more in this week’s Migraine Minute News Update.
Never want to miss an episode? Follow @migrainedisorders to catch these updates every week!
More info on stories we discussed:
https://bit.ly/2NckEiS
https://bit.ly/3q80pRO
https://bit.ly/2LEZDwP
https://bit.ly/371kjq1
Is smartphone use leading to more severe headache? Molly O’Brien will fill you in on that and more in this week’s Migraine Minute News Update.
Never want to miss an episode? Follow The Assoication of Migraine Disorders to catch these updates every week!
More info on the stories we talked about:
https://bit.ly/3jiSoa1
https://bit.ly/3oTpvCy
https://bit.ly/2O8PWHR
In this week’s Migraine Minute News Update, Molly O’Brien will fill you in on new migraine treatment options in the approval process and on the market
Never want to miss an episode?
Follow @migrainedisorders to catch these updates every week!
Want more information on the stories we talked about?
Check out these links:
https://bit.ly/2Yv9Hel
https://prn.to/2MwYZ4r
https://bit.ly/3t92Lle
https://bit.ly/3qYNOR0
In this week’s Migraine Minute News Update, Molly O'Brien will fill you in on the latest in pediatric abdominal migraine and more.
Never want to miss an episode? Follow the Association of Migraine Disorders to catch these updates every week!
More info on the stories discussed:
https://bit.ly/3sORJ4q
https://bit.ly/362nmOx
https://bit.ly/2Mhr5Ri
In this week’s Migraine Minute News Update,
Molly O’Brien will fill you in on the latest in migraine drug trials and approvals.
Never want to miss an episode?
Follow @migrainedisorders to catch these updates every week!
What does migraine treatment look like in the ER? Are you paying more to see a neurologist?
Molly O’Brien will fill you in on the latest research. Check out this week’s AMD Migraine Minute News Update.
Can moderate exercise help with episodic migraine?
Check out the Association of Migraine Disorders Migraine Minute News Update.
Molly O’Brien will fill you in on the latest research-- and find out which celebrity is promoting a new migraine drug.